How does obesity typically affect the volume of distribution for lipophilic drugs?

Prepare thoroughly for the MDC Pharmacokinetics Exam with our detailed guidance. Utilize flashcards and multiple-choice questions, complete with hints and explanations, to excel in your test!

Multiple Choice

How does obesity typically affect the volume of distribution for lipophilic drugs?

Explanation:
Obesity increases the volume of distribution for lipophilic drugs. Lipophilic compounds preferentially partition into adipose tissue, and with more fat mass there is a larger reservoir for these drugs. This means a greater amount of drug can spread out of the plasma into tissues for a given plasma concentration, raising the Vd (Vd = total amount in the body divided by plasma concentration). A higher Vd can also lengthen the drug’s apparent half-life if clearance remains unchanged, since t1/2 is proportional to Vd. The key idea is that fat tissue serves as a storage site for lipophilic drugs, and more fat shifts distribution toward a larger Vd.

Obesity increases the volume of distribution for lipophilic drugs. Lipophilic compounds preferentially partition into adipose tissue, and with more fat mass there is a larger reservoir for these drugs. This means a greater amount of drug can spread out of the plasma into tissues for a given plasma concentration, raising the Vd (Vd = total amount in the body divided by plasma concentration). A higher Vd can also lengthen the drug’s apparent half-life if clearance remains unchanged, since t1/2 is proportional to Vd. The key idea is that fat tissue serves as a storage site for lipophilic drugs, and more fat shifts distribution toward a larger Vd.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy